Cancer Treatment Reviews
Volume 31, Issue 3 , Pages 186-196 , May 2005

Prophylactic antibiotics for preventing early Gram-positive central venous catheter infections in oncology patients, a Cochrane systematic review

  • M.D. van de Wetering

      Affiliations

    • Paediatric Oncology Department, Emma Children’s Hospital/Academic Medical Centre, F8-245, Meibergdreef 9, 1105 AD Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 20 566 2727/3050; fax: +31 20 691 2231
    • ,
  • J.B.M. van Woensel

      Affiliations

    • Paediatric Intensive Care Unit/Emma Children’s Hospital Academic Medical Centre, Amsterdam, The Netherlands
    • ,
  • L.C.M. Kremer

      Affiliations

    • Paediatric Oncology Department, Emma Children’s Hospital/Academic Medical Centre, F8-245, Meibergdreef 9, 1105 AD Amsterdam, The Netherlands
    • Children’s Epidemiological Centre/Emma Children’s Hospital/Academic Medical Centre, Amsterdam, The Netherlands
    • ,
  • H.N. Caron

      Affiliations

    • Paediatric Oncology Department, Emma Children’s Hospital/Academic Medical Centre, F8-245, Meibergdreef 9, 1105 AD Amsterdam, The Netherlands

References 

  1. Groeger JS, Lucas AB, Thaler HT, et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med. 1993;119:1168–1174
  2. Groeger JS, Lucas AB, Coit D, et al. A prospective, randomized evaluation of the effect of silver impregnated subcutaneous cuffs for preventing tunneled chronic venous access catheter infections in cancer patients. Ann Surg. 1993;218:206–210
  3. Ingram J, Weitzman S, Greenberg ML, Parkin P, Filler R. Complications of indwelling venous access lines in the pediatric hematology patient: a prospective comparison of external venous catheters and subcutaneous ports. Am J Pediatr Hematol Oncol. 1991;13:130–136
  4. Press OW, Ramsey PG, Larson EB, Fefer A, Hickman RO. Hickman catheter infections in patients with malignancies. Medicine (Baltimore). 1984;63:189–200
  5. Flynn PM. Diagnosis, management and prevention of catheter-related infections. Sem Pediatr Infect Dis. 2000;11:113–121
  6. Salzman MB, Rubin LG. Intravenous catheter-related infections. Adv Pediatr Infect Dis. 1995;10:337–368
  7. Shaul DB, Scheer B, Rokhsar S, et al. Risk factors for early infection of central venous catheters in pediatric patients. J Am Coll Surg. 1998;186:654–658
  8. Hospital Infection Control Practices Advisory committee. Recommendations for the prevention of nosocomial intravascular device related infections. Am J Infection Contr 1990;24:277–93
  9. BCSH guidelines on the insertion and management of central venous lines. Br J Haematol 1997;98:1041–7
  10. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med. 2000;132:391–402
  11. Lim SH, Smith MP, Machin SJ, Goldstone AH. A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter-related sepsis in patients receiving intensive chemotherapy for haematologjcal malignancies. Eur J Haematol Suppl. 1993;(Suppl 54):10–13
  12. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001;32:1249–1272
  13. van Tulder MW, Assendelft WJ, Koes BW, Bouter LM. Method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group for spinal disorders. Spine. 1997;22:2323–2330
  14. Al Sibai MB, Harder EJ, Faskin RW, Johnson GW, Padmos MA. The value of prophylactic antibiotics during the insertion of long-term indwelling silastic right atrial catheters in cancer patients. Cancer. 1987;60:1891–1895
  15. Rubie H, Juricic M, Claeyssens S, et al. Morbidity using subcutaneous ports and efficacy of vancomycin flushing in cancer. Arch Dis Child. 1995;72:325–329
  16. Dawson S, Fitzgerald P, Langer JC, et al. A preoperative protocol for the prevention of infection in children with tunnelled right atrial catheters. Oncol Rep. 2000;7:1239–1242
  17. Carratala J, Niubo J, Fernandez-Sevilla A, et al. Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob Agents Chemother. 1999;43:2200–2204
  18. Raad II, Hachem RY, Abi-Said D, et al. A prospective crossover randomized trial of novobiocin and rifampin prophylaxis for the prevention of intravascular catheter infections in cancer patients treated with interleukin-2. Cancer. 1998;82:403–411
  19. Ljungman P, Hagglund H, Bjorkstrand B, Lonnqvist B, Ringden O. Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized, controlled study. Support Care Cancer. 1997;5:485–488
  20. Ranson MR, Oppenheim BA, Jackson A, Kamthan AG, Scarffe JH. Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. J Hasp Infect. 1990;15:95–102
  21. Vassilomanolakis M, Plataniotis G, Koumakis G, et al. Central venous catheter-related infections after bone marrow transplantation in patients with malignancies: a prospective study with short-course vancomycin prophylaxis [see comments]. Bone Marrow Transplant. 1995;15:77–80
  22. Daghistani D, Horn M, Rodriguez Z, Schoenike S, Toledano S. Prevention of indwelling central venous catheter sepsis. Med Pediatr Oncol. 1996;26:405–408
  23. Barriga FJ, Varas M, Potin M, et al. Efficacy of a vancomycin solution to prevent bacteremia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients. Med Pediatr Oncol. 1997;28:196–200
  24. Henrickson KJ, Axtell RA, Hoover SM, et al. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized, multicenter, double-blind trial. J Clin Oncol. 2000;18:1269–1278
  25. Rackoff WR, Weiman M, Jakobowski D, et al. A randomized, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children. J Pediatr. 1995;127:147–151
  26. Schwartz C, Henrickson KJ, Roghmann K, Powell K. Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol. 1990;8:1591–1597
  27. Keohane PP, Jones BJ, Attrill H, et al. Effect of catheter tunnelling and a nutrition nurse on catheter sepsis during parenteral nutrition. A controlled trial. Lancet. 1983;2:1388–1390
  28. Rizzari C, Palamone G, Corbetta A, Uderzo C, Vigano EF, Codecasa G. Central venous catheter-related infections in pediatric hematology-oncology patients: role of home and hospital management. Pediatr Hematol Oncol. 1992;9:115–123
  29. Carratala J. Role of antibiotic prophylaxis for the prevention of intravascular catheter-related infection. Clin Microbiol Infect. 2001;7(Suppl 4):83–90
  30. Segura M, Alvarez-Lerma F, Tellado JM, et al. A clinical trial on the prevention of catheter-related sepsis using a new hub model. Ann Surg. 1996;223:363–369
  31. Henrickson KJ, Dunne WM. Modification of central venous catheter flush solution improves in vitro antimicrobial activity [letter]. J Infect Dis. 1992;166:944–946
  32. Yao JD, Arkin CF, Karchmer AW. Vancomycin stability in heparin and total parenteral nutrition solutions: novel approach to therapy of central venous catheter-related infections. J Parenter Enteral Nutr. 1992;16:268–274

PII: S0305-7372(04)00190-2

doi: 10.1016/j.ctrv.2004.12.004

Cancer Treatment Reviews
Volume 31, Issue 3 , Pages 186-196 , May 2005

Article Tools

* Image Usage & Resolution